PT2921489T - Composto de 2-piridona - Google Patents

Composto de 2-piridona

Info

Publication number
PT2921489T
PT2921489T PT138555347T PT13855534T PT2921489T PT 2921489 T PT2921489 T PT 2921489T PT 138555347 T PT138555347 T PT 138555347T PT 13855534 T PT13855534 T PT 13855534T PT 2921489 T PT2921489 T PT 2921489T
Authority
PT
Portugal
Prior art keywords
pyridone compound
pyridone
compound
Prior art date
Application number
PT138555347T
Other languages
English (en)
Inventor
Kuroda Shoichi
Imai Yudai
Kawaguchi Takanori
Fusegi Keiko
Bohno Masahiro
Asanuma Hajime
Chonan Tomomichi
Sato Nagaaki
Monma Souichi
Sasako Shigetada
Mizutani Marie
Itoh Shin
Okada Takumi
Ota Hirofumi
Ishiyama Seishi
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of PT2921489T publication Critical patent/PT2921489T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
PT138555347T 2012-11-13 2013-11-12 Composto de 2-piridona PT2921489T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012249792 2012-11-13

Publications (1)

Publication Number Publication Date
PT2921489T true PT2921489T (pt) 2017-12-01

Family

ID=50731146

Family Applications (1)

Application Number Title Priority Date Filing Date
PT138555347T PT2921489T (pt) 2012-11-13 2013-11-12 Composto de 2-piridona

Country Status (26)

Country Link
US (1) US9695148B2 (pt)
EP (1) EP2921489B1 (pt)
JP (1) JP5963025B2 (pt)
KR (1) KR102160841B1 (pt)
CN (1) CN104768944B (pt)
AU (1) AU2013345930B2 (pt)
BR (1) BR112015010823A2 (pt)
CA (1) CA2891406C (pt)
DK (1) DK2921489T3 (pt)
ES (1) ES2641469T3 (pt)
HK (1) HK1207856A1 (pt)
HU (1) HUE034557T2 (pt)
IL (1) IL238701B (pt)
IN (1) IN2015DN03869A (pt)
MX (1) MX361479B (pt)
MY (1) MY173812A (pt)
NO (1) NO2921489T3 (pt)
NZ (1) NZ707832A (pt)
PH (1) PH12015501056A1 (pt)
PL (1) PL2921489T3 (pt)
PT (1) PT2921489T (pt)
RU (1) RU2662157C2 (pt)
SG (1) SG11201503716RA (pt)
TW (1) TWI591064B (pt)
WO (1) WO2014077235A1 (pt)
ZA (1) ZA201503323B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6048533B2 (ja) * 2014-05-12 2016-12-21 日産化学工業株式会社 ２−ピリドン化合物を含有する医薬
JPWO2015174377A1 (ja) * 2014-05-13 2017-04-20 日産化学工業株式会社 ２−ピリドン化合物の製造方法
CN110548026B (zh) 2018-05-31 2022-01-14 华领医药技术（上海）有限公司 含有葡萄糖激酶激活剂和k-atp通道阻断剂的药物组合及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275069A (en) 1979-01-22 1981-06-23 The Upjohn Company Anti-diabetic 1,2-dihydro-2-oxo-6-alkyl-nicotinic acids
DK1169312T3 (da) 1999-03-29 2005-01-31 Hoffmann La Roche Glucokinaseaktivatorer
US6353111B1 (en) 1999-12-15 2002-03-05 Hoffmann-La Roche Inc. Trans olefinic glucokinase activators
BRPI0712862A2 (pt) 2006-06-08 2012-12-18 Lilly Co Eli carboxamidas substituìdas
WO2008079787A2 (en) 2006-12-20 2008-07-03 Takeda San Diego, Inc. Glucokinase activators
PE20090449A1 (es) * 2007-07-17 2009-04-18 Bristol Myers Squibb Co Agonistas de receptor acoplado a proteina g gpr119 de piridona
JP2011529483A (ja) 2008-07-29 2011-12-08 ファイザー・インク フッ素化ヘテロアリール
BR112012013195A2 (pt) * 2009-12-04 2016-08-09 Nissan Chemical Ind Ltd compostos de 2-piridona.
JP2013010750A (ja) * 2011-06-02 2013-01-17 Taisho Pharmaceutical Co Ltd ２−ピリドン化合物を含有する医薬

Also Published As

Publication number Publication date
MX2015005884A (es) 2015-12-09
IL238701A0 (en) 2015-06-30
HUE034557T2 (en) 2018-02-28
NO2921489T3 (pt) 2018-02-03
PH12015501056B1 (en) 2015-07-27
PH12015501056A1 (en) 2015-07-27
RU2662157C2 (ru) 2018-07-24
JP5963025B2 (ja) 2016-08-03
AU2013345930B2 (en) 2017-08-24
NZ707832A (en) 2019-03-29
JPWO2014077235A1 (ja) 2017-01-05
IL238701B (en) 2018-10-31
CN104768944A (zh) 2015-07-08
PL2921489T3 (pl) 2018-01-31
TWI591064B (zh) 2017-07-11
TW201434826A (zh) 2014-09-16
CN104768944B (zh) 2017-03-29
DK2921489T3 (en) 2017-10-16
SG11201503716RA (en) 2015-06-29
US9695148B2 (en) 2017-07-04
ES2641469T3 (es) 2017-11-10
EP2921489A4 (en) 2016-04-06
KR20150082301A (ko) 2015-07-15
BR112015010823A2 (pt) 2017-07-11
IN2015DN03869A (pt) 2015-10-02
CA2891406A1 (en) 2014-05-22
KR102160841B1 (ko) 2020-09-28
EP2921489B1 (en) 2017-09-06
CA2891406C (en) 2021-03-16
HK1207856A1 (en) 2016-02-12
AU2013345930A1 (en) 2015-06-04
EP2921489A1 (en) 2015-09-23
MY173812A (en) 2020-02-24
RU2015122717A (ru) 2017-01-10
MX361479B (es) 2018-12-06
ZA201503323B (en) 2016-08-31
US20160289208A1 (en) 2016-10-06
WO2014077235A1 (ja) 2014-05-22

Similar Documents

Publication Publication Date Title
HK1203498A1 (en) Tetrahydropyrazolopyrimidine compounds
HK1198761A1 (en) Imidazopyrrolidinone compounds
EP2842955A4 (en) TRK-INHIBITING CONNECTION
EP2925129A4 (en) PRO-NEUROGENIC COMPOUNDS
GB201209138D0 (en) Compounds
GB201214750D0 (en) Compounds
GB201215357D0 (en) Compounds
EP2887803A4 (en) PRO-NEUROGENIC COMPOUNDS
HK1206726A1 (en) Imidazotriazinone compounds
GB201204985D0 (en) Compounds
GB201220843D0 (en) Compound
GB201204125D0 (en) Compounds
GB201209096D0 (en) Compounds
GB201219820D0 (en) Compounds
HK1206356A1 (en) Lpar - substituted cyanopyrazole compounds lpar-
HK1207856A1 (en) 2-pyridone compound 2-
GB201216309D0 (en) Compound
GB201215675D0 (en) Compound
GB201217310D0 (en) Compounds
HK1215569A1 (zh) 吡啶酮化合物
GB201216448D0 (en) Compound
GB201222716D0 (en) Compound
GB201223429D0 (en) Compounds
GB201220029D0 (en) Compounds
GB201219819D0 (en) Compounds